The use of radioisotopes for palliation of metastatic bone pain

dc.contributor.authorGkialas, I.en
dc.contributor.authorIordanidou, L.en
dc.contributor.authorGalanakis, I.en
dc.contributor.authorGiannopoulos, S.en
dc.date.accessioned2015-11-24T19:21:23Z
dc.date.available2015-11-24T19:21:23Z
dc.identifier.issn1107-0625-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22098
dc.rightsDefault Licence-
dc.subjectBone Neoplasms/*radiotherapy/*secondaryen
dc.subjectHumansen
dc.subjectNeoplasms/*complications/pathology/therapyen
dc.subjectPain/*etiology/*radiotherapyen
dc.subjectPalliative Care/*methodsen
dc.subjectRadioisotopes/*therapeutic useen
dc.subjectRadiopharmaceuticals/*therapeutic useen
dc.titleThe use of radioisotopes for palliation of metastatic bone painen
heal.abstractBone pain associated with advanced prostate and other cancers is a frequent and significant complication. Pharmaceutical therapy of bone pain includes nonsteroidal analgesics and opiates. While external beam radiation therapy remains the mainstay of pain palliation of solitary lesions, bone-seeking radiopharmaceuticals have entered the armamentarium for the treatment of multiple osseous metastases. The 3 radioisotopes currently approved for treatment of pain (strontium-89/(89)Sr, samarium-153/(153)Sm and rhenium-186/(186)Re) are discussed in this review including the approved dose, method of administration and indications for use.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/18555462-
heal.journalNameJ BUONen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2008-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: